Tuesday 9 July 2024 9:00am to 1:00pm
Babraham Institute, Babraham Research Campus Babraham Cambridge CB22 3AT
About
Akoya Biosciences Phenocycler technology has been used to perform multiplexed imaging of human atherosclerotic lesions using a panel comprised of the following markers - DAPI, CD45, MYH11, CD68, cleaved caspase 3, IL‐1β, TNF‐α, and BODIPY.